Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levobupivacaine vs Ropivacaine for Hip Fracture Block
NCT04773301Phase 4Completed
- Sponsor
- Fundación Instituto de Ciencias de la Salud de Castilla y León
- Start
- Feb 2021
- Primary completion
- Nov 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of levobupivacaine, ropivacaine in hip fracture, sponsored by Fundación Instituto de Ciencias de la Salud de Castilla y León. Started Feb 2021; status: completed.
02
Drugs
levobupivacaineropivacaine
03
Conditions
hip fracture
Beyond the preview
Go deeper on NCT04773301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04773301.